The Effects of Sedative on the Fluid Responsiveness in Critically Ill Patients
NCT ID: NCT01447875
Last Updated: 2014-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
100 participants
INTERVENTIONAL
2011-05-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sequential Use of Propofol/Midazolam and Dexmedetomidine for Sedation in Mechenical Ventialtion Patients in ICU.
NCT02122055
Impact of Various Sedation Regimens on the Incidence of Delirium
NCT02117726
Comparison the Hemodynamics Effects Between Dexmedetomidine and Propofol in Major Abdominal Surgical Patients
NCT01669044
Comparison Between Dexmedetomidine and Propofol for Patients in the Intensive Care Unit After Abdominal Surgery
NCT02874768
Dexmedetomidine Versus Propofol for Continuous Sedation in the Intensive Care Unit (ICU)
NCT00479661
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Passive Leg Raising
elevation of both legs to a 45 degrees for about 1-2 minute before sedation
propofol or mexmedetomidine
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* an increase in the intra-abdominal pressure confirmed by clinical examination
* serious central nervous system pathology (head trauma, severe dementia, acute stroke, uncontrolled seizures)
* severe liver disease(Child-Pugh class C)
* unstable angina or acute myocardial infarction
* left ventricular ejection fraction less than 30%
* heart rate(HR) less than 50/min, heart block with second- or third degree
* systolic blood pressure (SBP) less than 90 mmHg despite 2 vasopressors infusion continuously before the begin of dexmedetomidine infusion
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Southeast University, China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tao Yu
clinical doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tao Yu
Role: STUDY_DIRECTOR
Nanjing Zhong-Da Hospital, Southeast University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nanjing Zhong-Da Hospital, Southeast University School of Medicine
Nanjing, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011ZDLLKY02.1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.